Get started
Award

W20361-2-38

Funded outputs count: 4
Funder award ID: W20361-2-38
OpenAlex ID: G7749135252
Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy
2026 · Asli Özkan, Marieke IJsselsteijn, et al. · Journal for ImmunoTherapy of Cancer
PDF
Response to letter Re: Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors
2025 · Asli Özkan, Karlijn de Joode, et al. · European Journal of Cancer
Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors
2025 · Asli Özkan, Karlijn de Joode, et al. · European Journal of Cancer · 6
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
2024 · A. Özkan, E. Kapiteijn, et al. · European Journal of Cancer · 14
PDF
Year
Topic